By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a



Company News
Synergy Pharma Announces $89.8 Million Registered Direct Offering Of Common Stock 5/5/2016 10:50:43 AM
Synergy Pharma Announces Resignation Of Chief Financial Officer 4/28/2016 10:28:40 AM
Synergy Pharma To Present At The Deutsche Bank (DB) Health Care Conference 4/26/2016 11:43:06 AM
Synergy Pharma Announces Acceptance Of New Drug Application For Plecanatide, A Novel Uroguanylin Analog, In Chronic Idiopathic Constipation 4/19/2016 12:42:39 PM
Synergy Pharma Announces Closing Of Convertible Notes Exchanges 3/29/2016 11:15:42 AM
Synergy Pharma’ Exchange Agreements To Reduce 50% of Senior Notes Outstanding 3/21/2016 10:57:23 AM
Synergy Pharma Appoints Marino Garcia As Chief Strategy Officer 3/10/2016 10:35:09 AM
Synergy Pharma To Present At The 28th Annual ROTH Conference 3/8/2016 10:07:57 AM
Synergy Pharma Reports 2015 Fourth Quarter, Full-Year Financial Results And Business Update 2/26/2016 8:20:52 AM
BIND Therapeutics (BIND) And Synergy Pharma Announce Collaboration To Develop ACCURINS® With Proprietary Uroguanylin Analogs For Targeting Gastrointestinal Receptors On Tumors 2/16/2016 11:06:15 AM